{
    "2021-12-27": [
        [
            {
                "time": "2021-12-15",
                "original_text": "COVID-19: ‘We don’t really know what Omicron is going to do in terms of Long-COVID,’ doctor says",
                "features": {
                    "keywords": [
                        "Omicron",
                        "Long-COVID",
                        "uncertainty"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Gilead Sciences sued over royalty payments on key HIV drug",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "royalty payments",
                        "HIV drug"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Stock market outlook: Sectors to watch going into 2022",
                "features": {
                    "keywords": [
                        "stock market outlook",
                        "sectors",
                        "2022"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "multiple"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Gotham owner details staffing and inflation challenges restaurants are facing",
                "features": {
                    "keywords": [
                        "Gotham owner",
                        "staffing",
                        "inflation",
                        "restaurants"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "hospitality"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Retail analyst: Department stores have ‘proved they’re resilient’",
                "features": {
                    "keywords": [
                        "retail analyst",
                        "department stores",
                        "resilient"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "retail"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Omicron: ‘It’s morally scandalous’ that we don’t have adequate COVID testing, doctor says",
                "features": {
                    "keywords": [
                        "Omicron",
                        "morally scandalous",
                        "COVID testing"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Omicron: Less severe infection rate has been ‘downplayed,’ former FDA official says",
                "features": {
                    "keywords": [
                        "Omicron",
                        "less severe",
                        "downplayed",
                        "FDA"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Johnson & Johnson Stock: Bull vs. Bear",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Bull vs. Bear"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "COVID-19 cases rise amid Omicron, CDC shortens isolation guidelines for health care workers",
                "features": {
                    "keywords": [
                        "COVID-19 cases",
                        "Omicron",
                        "CDC",
                        "isolation guidelines"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "Sitting on Cash? These 2 Stocks Are Great Buys",
                "features": {
                    "keywords": [
                        "Sitting on Cash",
                        "Great Buys"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "multiple"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}